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Abstract A novel O-acetylated GM3 containing 3-O-acetyl 4- 
sphingenine was isolated with one having a non-aeetylated base 
from transplanted rat glioma tissue. The presence and position 
of the acetyl group were estimated by one- and two-dimensional 
proton nuclear magnetic resonance, and fast atom bombardment- 
mass spectrometries. In addition, the O-acetyl GM3 showed 
higher immunological activity toward anti-melanoma ntibody in 
the presence of non-acetylated GM3 in complement-dependent 
liposome lysis than did non-acetylated or acetylated GM3 alone 
in the liposome, suggesting enhancement of immunological reac- 
tivity of the intact tumor cells by a small amount of O-acetyl 
GM3. 
Eey words: Ganglioside; Glioma; O-Acetyl sphingenine; O-
kcetyl ceramide;O-Acetyl GM3; Rat 
i. Introduction 
Gangliosides (Ggls) and their O-acetylated derivatives have 
~een minutely investigated aspotential tumor-associated anti- 
:gens. Many O-acetylated Ggls have been isolated from normal 
md tumor tissues or cells and their immunological ctivities 
~;oward monoclonal ntibodies raised against umor cells have 
been characterized. For instance, 9-O-acetyl (Ac) GD3 (9-0- 
~-c,N-Ac neuraminyl,N-Ac neuraminyllactosylceramide) was 
Jetected with an antibody as human melanoma-associated Ggl 
~n melanoma tissue [1,2] and in fluids from patients [3], as well 
.as being purified from melanoma cells [4] and human butter- 
milk [5], followed by characterization f the structure mainly 
by means of NMR spectroscopy. Other O-acetylated Ggls on 
the sialic acid moiety have been obtained from mammalian 
tissues and fluids [6-9] and from fish [10,11]. All these Ggls 
could be biochemically modified species from respective parent 
Ggls in normal or tumor cells by enzymatic O-acetylation [12] 
or intramolecular migration [13] after O-acetylation atthe sialic 
acid, and not at the lipid moiety. Modification with the O-Ac 
residue at the latter has not yet been reported. 
With respect to glycosphingolipids (GSLs) in glioma, human 
tumor tissue was found, in general, to contain a low concentra- 
*Corresponding author. Fax: (81) (11) 612-5861. 
Abbreviations: GSL, glycosphingolipid; Ggl, ganglioside; Ac, acetyl; 
Cer, ceramide containing 4-sphingenine; GM3, N-acetylneuraminyl- 
lactosylceramide; 2D COSY, two-dimensional chemical shift-corre- 
lated spectroscopy; FAB-MS, fast atom bombardment-mass spectrom- 
etry; TLC, thin-layer chromatography; CMW, chloroform/methanol/ 
water. 
tion of Ggl, increased proportions of GM3, GM2 and GD3, 
and decreased proportions of the major normal brain Ggls 
[14,15]. In addition, we also isolated a buman blood group 
B-active GSL, belonging to the ganglio series, from rat glioma 
cell line RG2 subcutaneous isografts [16]. We have continued 
examination of the acidic GSL component of rat glioma 
isografts, finding a novel O-acetylated GM3 containing 3-O-Ac 
4-sphingenine. Furthermore, the immunological reactivity of 
the isolated O-Ac GM3 using liposomes i  also demonstrated 
in this report. 
2. Materials and methods 
2.1. Materials" 
Monoclonal antibody M2590 against GM3 from murine melanoma 
cells was obtained from COSMO Bio Co. (Tokyo). Guinea pig comple- 
ment was a generous gift from Dr. Hiroki Mori, Department ofMicro- 
biology, Faculty of Pharmaceutical Science, Health Science University 
of Hokkaido. High performance precoated thin-layer chromatography 
(TLC) plates (silica gel) and deuterized dimethylsulfoxide (M 2SO-d6) 
were purchased from Merck (Germany). Authentic GM3 was isolated 
from rat liver in this laboratory. Other reagents were of analytical 
grade. 
2.2. Purification of ganglioside J?om rat glioma tissue 
Rat glioma tissue was obtained from normal Fisher ats after trans- 
plantation of cell line RG2, as reported previously [16]. The acidic lipid 
fraction of chloroform/methanol/water (CMW) extracts from the tissue 
(1,235 g wet wt.) was isolated by anion-exchange column chromatogra- 
phy using DEAE-Sephadex A-25 (Pharmacia-LKB, Uppsala, Sweden), 
and was repeatedly chromatographed on a silica gel column (Iatron, 
Tokyo) without saponification u til the sugar moiety of the isolated 
Ggl appeared to be homogeneous nder proton NMR analysis. GSL 
from normal Fisher at brain was also purified without alkaline treat- 
ment as described above. Each purified GSL was analyzed for chemical 
structure as below. 
2.3. ,Saponification f purified O-Ac gangliosides 
The purified O-Ac Ggl (0.1 mg) was treated with 1 ml of 1% sodium 
metho×ide in methanol for 2 h at room temperature, followed by neu- 
tralizing with acetic acid. The saponified Ggl was obtained after re- 
moval of salt from the mixture by gel-filtration chromatography using 
a Sephadex LH-20 (Pharmacia-LKB, Uppsala, Sweden) column (1 x 20 
cm) by running with CMW (60:30:4.5). 
2.4. NMR and mass pectrometries 
The one-dimensional (1D) or 2D NMR spectrum of purified GSL 
(1-5 mg) was measured ina solution of Me2SO-dJD20 (98:2) at 90°C 
by 500 MHz, in Hokkaido University High-Resolution NMR Labora- 
tory, as reported earlier [17]. The fast atom bombardment-mass spec- 
trum (FAB-MS) of intact Ggl was obtained on a JEOL HX-500 appa- 
ratus at Analytical Center, Hokkaido University, using triethanol 
amine as a matrix, as reported previously [17]. 
2.5. Immunological studies 
Immunostaining of Ggl on a TLC aluminum plate was performed as 
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previously described [I 7] by a modification of the procedure of Mag- 
nani et al. [18]. Immunological reactivity of purified O-Ac GM3 toward 
anti-melanoma antibody was examined ina liposome lysis system de- 
pending on complement according to the method of Nores et al. [19], 
with some modification. Briefly, 500 nmol of both cholesterol and 
dipalmitoyl phosphatidylcholine, 20 nmol of dicetylphosphate nd var- 
iable amounts of O-Ac GM3, GM3 or a mixture of both (O-Ac GM3/ 
GM3, 65:35) were dried and dispersed in 0.1 ml of marker solution 
containing 0.1 M 4-methyl-umberiferyl phosphate (Wako Pure Chemi- 
cals, Tokyo). The resultant liposomes were thoroughly dialyzed against 
20 mM Tris-HCl, pH 8.0, containing 150 mM NaC1 to remove un- 
trapped fluorescence marker. Aliquots of the liposome suspension were 
incubated with 1 mg per ml of M2590 antibody and guinea pig comple- 
ment. The liberation of 4-methylumberiferone fromthe liposomes was 
measured with a spectrofluorophotometer (RE-510; Shimadzu) after 
incubation with alkaline phosphatase (E. coli, type III; Sigma) for 10 
min at room temperature. Each assay was performed intriplicate and 
plotted as mean values in Fig. 4C. 
3. Results and discussion 
3.1. Isolation of  O-Ac GM3 
A GM3 that migrated slightly faster than authentic GM3 was 
purified together with the ordinary GM3 from the glioma acidic 
fraction as demonstrated in Fig. 1. The oligosaccharide struc- 
tures of these GM3s were independently confirmed by gas 
chromatography-mass spectrometry of partially methylated 
alditol acetates (data not shown), and by 1D NMR and FAB- 
MS spectra. The faster-migrating GM3 was saponified to give 
an Rr spot similar to that of standard GM3 (Fig. 1), dem- 
onstrating an alkaline-labile group bound to the Ggl molecule 
responsible for the faster migration. The yield of whole GM3 
containing the faster-migrating form was 28 mg from 1.235 g 
of wet wt. tissue. 
3.2. FAB-MS study 
As demonstrated in Fig. 2, the main pseudo molecular ion 
of the GM3 at m/z 1305 was due to a GM3 molecule 
(Mr = 1264) including an additional Ac residue, composed of 
sphingenine asa long chain base, 24:0 as a fatty acyl and an 
N-Ac-neuraminic a id moiety. The other molecular ions at m/z 
1333, 1277, 1249, 1221 and 1193 were consequently assigned to 
100 
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Fig. 1. Thin layer chromatography of GM3 from rat glioma subcutane- 
ous isografts, The crude acidic fraction (A) and isolated GM3 (13) from 
rat glioma were chromatographed on TLC, developed with CMW 
(60:35:8) and stained by orcinol-sulfuric a id. (A) Std, acidic fraction 
of rat whole brain; lane 1, acidic fraction from rat glioma; CS, sulfated 
GalCer. (B) Std, standard GM3; lane 1, glioma O-Ac GM3; 2, glioma 
GM3; 3, saponified O-Ac GM3. O, origin. 
monoAc GM3 with 26: 0, 22: 0, 20: 0, 18 : 0 and l 6: 0 as the fatty 
acyls. The fragment ions due to mono-Ac-dihexosylceramide 
(O-Ac LacCer in the figure), -monohexosylCer (O-Ac GlcCer) 
and -Cer were also observed with the same lipid species as those 
of the Ac GM3. These fragments indicate the presence of 
monoAc group on Cer of the GM3 molecule, not on the sugar 
moiety. The Ac group presumably attaches to hydroxyl oxygen 
at C-3 of sphingenine, since the Cer moiety of the GM3 was 
composed of sphingenine (98%) and non-hydroxy fatty acids 
(26:0, 9%; 24:0, 35; 22:0, 12; 20:0, 16; 18:0, 23; 16:0, 3; and 
others) as analyzed by gas-layer chromatography. 
3.3. NMR study 
The 1D NMR spectrum of the faster-migrating GM3 is 
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Fig. 2. Negative FAB-MS spectrum of O-Ac GM3. The numbers in parentheses at the fragment indicate carbon number and unsaturated grade of 
fatty acid. 
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Fig. 3. 1D (A) and 2D (B) NMR spectra of O-Ac GM3. L, long chain base; S, sialic acid, I ~, H-1 on Glc; II 1, H-1 on Gal; L 2 3, connectivity between 
H-2 and H-3 on the long chain base. The peak marked with an asterisk is a contaminant. 
shown in Fig. 3A, demonstrating a typical singlet IH at 81.959 
due to O-Ac-methyl ~Hs, a lower field-shifted triplet 1H at 5.224 
(abbreviated asL3), probably due to 1H attached to the carbon 
with an acetoxy group, and olefinic ~Hs at 5.402 and 5.679 due 
to ~Hs attached to the C-4 and -5 on sphingenine, respectively. 
These nHs as well as other ~Hs were assigned by 2D chemical 
shift-correlated spectroscopy (COSY) as shown in Fig. 3B, and 
summarized in Table 1. The partial 2D spectrum of the Ac 
GM3 showed that L 3 coupled both with a broad L 2, overlapped 
with the anomeric 1H (I j) on Glc, and olefinic L 4 judged from 
the presence of cross-peaks L 2-3 and L 3~, respectively, and that 
the L 2 further coupled with L ma nd L ~b from L ma 2 and L ~w2 and 
with amide 1H (LNH), which was previously assigned to the ~H 
bearing on the Cer moiety [16,17], from L NH 2. Based on these 
couplings, the ~Hs from L ~ to L 5 were assigned to H-1 to H-5, 
respectively, on sphingenine, and therefore, an Ac group was 
confirmed to exist at C-3-O on sphingenine of the GM3. Thus, 
the assigned C-3-H on sphingenine was detected neither in any 
neutral GSLs from glioma, nor in any GSLs from normal rat 
brain, indicating the occurrence of non-acetylation on these 
GSLs, and further suggesting that expression of O-Ac Cer on 
GM3 might be a tumor-associated phenomenon. 
The O-acetylated sialylparagloboside at the Cer was also 
obtained from the tissue as a minor Ggl (data not shown). The 
presence of an O-acetyltransferase acting on the long chain 
base has been reported earlier only in yeast [20]. The present 
report might be, therefore, the first evidence of this in mammal- 
ian tissue, if Ggls or the precursor lipids were acetylated by 
O-acetyltransferase which would exist in glioma. The extent of 
the lipid O-acetylation i glioma GM3 was estimated with inte- 
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Fig. 4. Immunological ctivity of O-Ac GM3: (A) stained with orcinol-sulfuric acid; (B) immunostained on TLC with M2590 using 1/100 of the 
respective lipids in panel A. Lane 1, authentic GM3; 2, glioma GM3; 3, O-Ac GM3. (C) Result from antibody complement-dependent liposome lysis. 
Abscissa indicates the amount of antigen GM3s (mol%) added when the liposomes were prepared. ©, liposome with GM3; ~, O-Ac GM3; &, a mixture 
of GM3 and O-Ac GM3 in a molar ratio of 65 : 35. 
gration of H-5 (LS), the chemical shift of which was distinct 
between O-acetylated and non-acetylated Ggls (see Table 1), to 
35%. 
3.4. Immunological study of O-Ac GM3 
The antigenicity of the purified O-Ac GM3 from glioma was 
estimated using an antibody against murine melanoma, M2590, 
which reacted with GM3 and GM3 lactone containing N-Ac- 
neuraminic acid [21], revealing that O-Ac GM3 was strongly 
stained by the antibody together with non-acetylated GM3, as 
demonstrated in Fig. 4B. Furthermore, in the study using com- 
plement-dependent liposome lysis, at 10 mol% of antigen, li- 
posomes independently with GM3 and with O-Ac GM3 re- 
leased 12% and 0%, respectively, of  trapped fluorescence, 
whereas that with mixed antigen with GM3 and O-Ac GM3 
liberated 42% of the marker, as shown in Fig. 4C. These data 
indicate that liposomes with mixed antigen, in which the ratio 
of the composition might be close to that of intact glioma cells 
regardless of other lipid components, were significantly more 
sensitive to the melanoma ntibody than liposomes with GM3 
or O-Ac GM3 only. A threshold density with recognition by 
the antibody in an all-or-none pattern was observed, in agree- 
ment with a previous result [19], but the tool% extent at the 
threshold was slightly different in the GM3 liposomes. Though 
it is not clear why liposomes with O-Ac GM3 had much weaker 
reactivity toward antigen than liposomes with GM3, or why the 
existence of the inferior reactive O-Ac GM3 on liposomes en- 
hanced the activity, evidence that GSLs form a cluster in the 
cell membranes [22] led us to consider preferential forming of 
the cluster to react with the antibody through the presence of 
the O-Ac GM3, and/or extended exposure of  the carbohydrate 
moiety above the membranes by the introduction of a hydro- 
phobic and sterically hindered Ac residue in the lipid portion, 
as compared to those from non-acetylated GM3. Further inves- 
tigation is required for clarification. 
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NMR chemical shift (8, ppm) of O-Ac GM3 and reference ceramide (Cer) contained in GM3 
H-1 a H-1 b H-2 H-3 H-4 H-5 H-6 a H-6 b H-7 H-8 H-9 a H-9 b -CONH- CH3CO- 
O-Ac GM3 a 
Cer 3.450 3.808 4.16 5.224 5.402 5.679 1.963 - - - 7.356 1.956 
fl-Glc 4.159 - 3.17 3.32 3.3 3.3 3.620 3.77 . . . . . .  
fl-Gal 4.220 - 3.321 4.007 3.780 3 .35  3 .483 3.610 - - - 
NeuAC - - 1.386 b 3.610 3.515 3.518 - 3.239 3.39 3.39 3.594 7.678 1.881 
2.757 c
GM3 
Cer d 3.513 3.945 3.79 3.951 5.391 5.562 1.950 . . . . .  7.285 
Cer e 3.432 3.993 3.769 3.876 5.343 5.533 1.931 . . . . .  r 
Measured at 90°C. 
bAx ill. 
~Eq tH. 
° Measured at 30°C [23]. 
f Not reported. 
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